🔬 Health & Fitness Research
Osteoboost Health’s FDA-cleared bone density wearable just legitimized wearables as medical devices—their trial showed 85% reduction in spine bone loss and 55% in hip loss over 12 months, making this the first non-drug treatment for postmenopausal osteopenia and a watershed moment for women’s health tech. If insurers start covering it, prevention stops being optional and becomes the standard.
Source: HIT Consultant
